Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 1
1975 1
1980 1
1981 1
1984 1
1985 2
1987 2
1988 7
1989 2
1990 2
1991 2
1992 4
1993 7
1994 5
1995 11
1996 4
1997 8
1998 6
1999 15
2000 9
2001 5
2002 16
2003 25
2004 22
2005 34
2006 41
2007 44
2008 58
2009 53
2010 76
2011 86
2012 106
2013 143
2014 169
2015 153
2016 178
2017 211
2018 215
2019 257
2020 284
2021 382
2022 424
2023 49
Text availability
Article attribute
Article type
Publication date

Search Results

2,787 results
Results by year
Filters applied: . Clear all
Page 1
Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome.
Su H, Yang F, Fu R, Trinh B, Sun N, Liu J, Kumar A, Baglieri J, Siruno J, Le M, Li Y, Dozier S, Nair A, Filliol A, Sinchai N, Rosenthal SB, Santini J, Metallo CM, Molina A, Schwabe RF, Lowy AM, Brenner D, Sun B, Karin M. Su H, et al. Among authors: fu r. Nature. 2022 Oct;610(7931):366-372. doi: 10.1038/s41586-022-05169-z. Epub 2022 Oct 5. Nature. 2022. PMID: 36198801
Cannabis-Based Products for Chronic Pain : A Systematic Review.
McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. McDonagh MS, et al. Among authors: fu r. Ann Intern Med. 2022 Aug;175(8):1143-1153. doi: 10.7326/M21-4520. Epub 2022 Jun 7. Ann Intern Med. 2022. PMID: 35667066 Free article. Review.
Prognostic Potential of METTL7B in Glioma.
Fu R, Luo X, Ding Y, Guo S. Fu R, et al. Neuroimmunomodulation. 2022;29(3):186-201. doi: 10.1159/000519778. Epub 2022 Jan 14. Neuroimmunomodulation. 2022. PMID: 35034026
Secukinumab demonstrates efficacy, safety, and tolerability upon administration by 2 ml autoinjector in adult patients with plaque psoriasis: 52-week results from MATURE, a randomized, placebo-controlled trial.
Sigurgeirsson B, Browning J, Tyring S, Szepietowski JC, Rivera-Díaz R, Effendy I, Keefe D, Bruin G, Paguet B, Fu R, Hampele I, Reinhardt M, Patekar M. Sigurgeirsson B, et al. Among authors: fu r. Dermatol Ther. 2022 Mar;35(3):e15285. doi: 10.1111/dth.15285. Epub 2022 Jan 8. Dermatol Ther. 2022. PMID: 34954841 Clinical Trial.
2,787 results